ARCHIVES

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

This article is from The Cancer Letter archive.

Vol. 37 No. 40 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed

April 22, 1977

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Trials Approved by NCI CTEP For the Month of May

May 25, 2012

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

CGOP Gets New Life, Will Move T DCT; DCPC May Fund More CCOPs with Money It Saves

July 25, 1986

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987